Mammographic surveillance after breast cancer
Open Access
- 6 March 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1157) , 882-885
Abstract
Early detection of local recurrence has been shown to improve survival. What is unclear is how frequently mammography should be performed, how long surveillance should continue and how the answers to these questions vary with tumour pathology, patients age, and surgery type. Many of these questions are not directly answerable from the current literature. While some of these questions will be answered by the Mammo-50 study, evidence from local recurrence rates, tumour biology, and the lead time of mammography can be used to guide policy. Young age is the strongest predictor of local recurrence and given the short lead time of screening in women under 50, these women require annual mammography. Women over 50 with HER-2 positive and triple negative breast cancer have higher rates of local recurrence after breast conserving surgery than women with luminal cancers. Women with HER-2 positive and triple negative breast cancer also have a higher rate of recurrence in years 1-3 post surgery. Annual mammography in year 1-4 would appear justified. Women over 50 with luminal cancers have low rates of local recurrence and no early peak. Recurrence growth will be low due to tumour biology and hormone therapy. Biennial mammography after year 2 would seem appropriate. Women over 50 following mastectomy have no early peak in contralateral cancers so the frequency should be determined by the lead time of screening. This would suggest 2 yearly mammography for women aged 50-60 while 3 yearly mammography may suffice for women over 60.Keywords
Funding Information
- National Institute for Health
- Care Research Health Technology Assessment (11/25/03)
This publication has 28 references indexed in Scilit:
- Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivorsBreast Cancer Research and Treatment, 2022
- Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 studyThe Breast, 2022
- Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysisThe Breast, 2019
- Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future researchBreast Cancer Research and Treatment, 2013
- High Mammographic Breast Density Is Independent Predictor of Local But Not Distant Recurrence After Lumpectomy and Radiotherapy for Invasive Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2008
- Mammographic Appearance of Recurrent Breast Cancer after Breast Conservation TherapyAcademic Radiology, 2008
- Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?European Journal of Cancer, 2003
- Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancerBreast Cancer, 2002
- Do mammographic features of locally recurrent breast cancer mimic those of the original tumour?The Breast, 1996